Dan Yuan

University of Washington, Seattle, Seattle, WA 
"Dan Yuan"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chour W, Choi J, Xie J, et al. (2023) Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis. Communications Biology. 6: 528
Duvvuri VR, Baumgartner A, Molani S, et al. (2022) Angiotensin-Converting Enzyme (ACE) Inhibitors May Moderate COVID-19 Hyperinflammatory Response: An Observational Study with Deep Immunophenotyping. Health Data Science. 2022
Goldman JD, Wang K, Röltgen K, et al. (2022) Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report. Vaccines. 11
Thompson RC, Simons NW, Wilkins L, et al. (2022) Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae. Nature Medicine
Yuan D, Zhang Y, Li Y, et al. (2022) CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study. Infection and Drug Resistance. 15: 6985-6999
Heath J, Chour W, Choi J, et al. (2022) Large libraries of single-chain trimer peptide-MHCs enable rapid antigen-specific CD8+ T cell discovery and analysis. Research Square
Su Y, Yuan D, Chen DG, et al. (2022) Multiple early factors anticipate post-acute COVID-19 sequelae. Cell
Krämer B, Knoll R, Bonaguro L, et al. (2021) Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity
Lee JW, Su Y, Baloni P, et al. (2021) Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nature Biotechnology
Su Y, Chen D, Yuan D, et al. (2020) Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell
See more...